IN2014MU00667A - - Google Patents

Info

Publication number
IN2014MU00667A
IN2014MU00667A IN667MU2014A IN2014MU00667A IN 2014MU00667 A IN2014MU00667 A IN 2014MU00667A IN 667MU2014 A IN667MU2014 A IN 667MU2014A IN 2014MU00667 A IN2014MU00667 A IN 2014MU00667A
Authority
IN
India
Prior art keywords
relates
transdermal gel
testosterone
administering
pharmaceutically acceptable
Prior art date
Application number
Other languages
English (en)
Inventor
Sehgal Ashish
Bhaskar Pallerla
Patel Aditya
Dadhaniya Dhaval
Original Assignee
Intas Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intas Pharmaceuticals Ltd filed Critical Intas Pharmaceuticals Ltd
Priority to IN667MU2014 priority Critical patent/IN2014MU00667A/en
Priority to PCT/IN2015/000101 priority patent/WO2015128876A2/fr
Priority to US15/121,269 priority patent/US20160361321A1/en
Publication of IN2014MU00667A publication Critical patent/IN2014MU00667A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN667MU2014 2014-02-25 2015-02-23 IN2014MU00667A (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IN667MU2014 IN2014MU00667A (fr) 2014-02-25 2015-02-23
PCT/IN2015/000101 WO2015128876A2 (fr) 2014-02-25 2015-02-23 Gel transdermique stable à base de testostérone
US15/121,269 US20160361321A1 (en) 2014-02-25 2015-02-23 Stable transdermal testosterone gel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN667MU2014 IN2014MU00667A (fr) 2014-02-25 2015-02-23

Publications (1)

Publication Number Publication Date
IN2014MU00667A true IN2014MU00667A (fr) 2015-10-23

Family

ID=54009732

Family Applications (1)

Application Number Title Priority Date Filing Date
IN667MU2014 IN2014MU00667A (fr) 2014-02-25 2015-02-23

Country Status (3)

Country Link
US (1) US20160361321A1 (fr)
IN (1) IN2014MU00667A (fr)
WO (1) WO2015128876A2 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
EP1634583A1 (fr) * 2004-09-09 2006-03-15 Laboratoires Besins International Gels de testostérone comprenant du propylèneglycol comme promoteur d'absorption
CN101287470B (zh) * 2005-10-12 2012-10-17 优尼麦德药物股份有限公司 改良的睾酮凝胶及使用方法

Also Published As

Publication number Publication date
US20160361321A1 (en) 2016-12-15
WO2015128876A3 (fr) 2015-11-05
WO2015128876A2 (fr) 2015-09-03

Similar Documents

Publication Publication Date Title
MX2023000320A (es) Metodos para modular los niveles de farmaco en plasma mediante el uso de eritrohidroxibupropion.
CA2956871C (fr) Composes actifs envers des bromodomaines
IL287604A (en) Formulations of pthrp analogs, their transdermal dressings and their uses
PH12016501830A1 (en) Inhibitors of c5a for the treatment of viral pneumonia
EP3206706A4 (fr) Composition injectable stable d'agents pharmaceutiquement actifs et procédé de préparation associé
MX2023006706A (es) Administracion transdermica de agentes grandes en composiciones de emulsion mediante acondicionamiento de la piel con microagujas y sus usos.
PH12017500239A1 (en) Abiraterone acetate formulation and methods of use
IN2014MU00303A (fr)
MX2017011521A (es) Composiciones topicas que comprenden un corticosteroide.
IN2013MU00711A (fr)
WO2015023649A3 (fr) Peptides destinés à améliorer l'administration transdermique
AU2018253600A1 (en) Dosage forms and therapeutic uses of l-4-chlorokynurenine
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
EP3265060A4 (fr) Cochléates et procédés pour les utiliser afin d'améliorer la pénétration tissulaire d'un agent pharmacologiquement actif
UA118474C2 (uk) (s)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині
PH12016501434A1 (en) Compositions for use in the treatment of allergic conditions
MX2016005545A (es) Analogo de la relaxina humana, composicion farmaceutica del mismo y aplicacion farmaceutica del mismo.
MX2018005350A (es) Formulacion de combinacion de dosis fija, eflornitina y sulindaco.
MX2021003908A (es) Polipeptidos de accion prolongada y metodos para su produccion y administracion.
EP3100744A4 (fr) Composition accélérant la pénétration cutanée, préparation pour administration transdermique, et préparation pour patch cutané
PH12017501979A1 (en) Pharmaceutical compound
MX2017010304A (es) Composiciones farmaceuticas que comprenden meloxicam.
EP3100743A4 (fr) Composition pour accélérer la pénétration à travers la peau, préparation pour administration transdermique, et préparation pour timbre transdermique
IN2014MU00667A (fr)
NZ725354A (en) Transdermal formulations of pergolide and uses thereof